Affiliation:
1. Department of Orthopaedic Surgery, Center for Bone Quality Leiden University Medical Center Leiden The Netherlands
2. Department of Internal Medicine, Division of Endocrinology, Center for Bone Quality Leiden University Medical Center Leiden The Netherlands
3. Skeletal Disorders & Mineral Homeostasis Section, National Institute of Dental and Craniofacial Research National Institutes of Health Bethesda MD USA
4. Department of Orthopaedic Surgery Nemours Children's Hospital Orlando FL USA
5. Metabolic Bone Disorders Unit, National Institute of Dental and Craniofacial Research National Institutes of Health Bethesda MD USA
Abstract
ABSTRACTThis study aimed to evaluate the prevalence of and risk factors for coxa vara deformity in patients with fibrous dysplasia/McCune‐Albright syndrome (FD/MAS). This study was conducted at the National Institutes of Health and Leiden University Medical Center. All patients with any subtype of FD/MAS, FD involving the proximal femur, one or more X‐rays available and age <30 years were included. X‐rays were scored for the neck‐shaft angle (NSA). Varus deformity was defined as NSA <110 degrees or >10 degrees below age‐specific values. Risk factors for deformity were assessed by nested case–control analysis, comparing patients and femurs with and without deformity, and by linear mixed effects model, modeling temporal NSA decrease (the natural course of the NSA) in non‐operated femurs with two or more X‐rays. Assessed variables included growth hormone excess, hyperthyroidism, hypophosphatemia, >25% of the femur affected, calcar destruction, radiolucency, and bilateral involvement. In total 180 patients were studied, 57% female. Mean ± SD baseline age was 13.6 ± 7.5 years; median follow‐up 5.4 (interquartile range [IQR], 11.1) years. Sixty‐three percent (63%) were diagnosed with MAS. A total of 94 patients were affected bilaterally; 274 FD femurs were analyzed; 99 femurs had a varus deformity (36%). In the nested case–control analysis, risk factors were as follows: presence of MAS (p < 0.001), hyperthyroidism (p < 0.001), hypophosphatemia (p < 0.001), high percentage of femur affected (p < 0.001), and calcar destruction (p < 0.001). The linear mixed effects model included 114 femurs, identified risk factors were: growth hormone excess (β = 7.2, p = 0.013), hyperthyroidism (β = 11.3, p < 0.001), >25% of the femur affected (β = 13.2, p = 0.046), calcar destruction (β = 8.3, p = 0.004), radiolucency (β = 3.9, p = 0.009), and bilateral involvement (β = 9.8, p = 0.010). Visual inspection of the graph of the model demonstrated most progression of deformity if NSA <120 degrees with age < 15 years. In conclusion, in tertiary care centers, the prevalence of FD/MAS coxa vara deformity was 36%. Risk factors included presence of MAS, high percentage of femur affected, calcar destruction, radiolucency, NSA <120 degrees and age < 15 years. © 2023 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).
Funder
Amgen
Bontius Stichting
Ultragenyx Pharmaceutical
Publisher
Oxford University Press (OUP)
Subject
Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献